Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort

M.S. Walma, L.J. Brada, S.I.S. Patuleia, J.G. Blomjous, T.L. Bollen, K. Bosscha, R.C. Bruijnen, O.R. Busch, G.J. Creemers, F. Daams, R. van Dam, S. Festen, D.J. de Groot, J.W. de Groot, N.H. Mohammad, J.J. Hermans, I.H. de Hingh, E.D. Kerver, M.S. van Leeuwen, C. van der LeijM.S. Liem, K.P. van Lienden, M. Los, V.E. de Meijer, M.R. Meijerink, L.J. Mekenkamp, J. Nederend, C.Y. Nio, G.A. Patijn, M.B. Polee, J.F. Pruijt, N.S. Renken, S.J. Rombouts, T.J. Schouten, M.W.J. Stommel, M.E. Verweij, J. de Vos-Geelen, J.J.J. de Vries, A. Vulink, F.J. Wessels, J.W. Wilmink, H.C. van Santvoort, M.G. Besselink*, I.Q. Molenaar, Dutch Pancreatic Canc Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)699-707
Number of pages9
JournalEuropean Journal of Surgical Oncology
Volume47
Issue number3
DOIs
Publication statusPublished - 1 Mar 2021

Keywords

  • folfirinox
  • locally advanced pancreatic cancer
  • treatment strategies
  • FOLFIRINOX
  • Locally advanced pancreatic cancer
  • Treatment strategies

Cite this